Global Whole Cell Cholera Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Whole Cell Cholera Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Whole Cell Cholera Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Whole Cell Cholera Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Whole Cell Cholera Vaccine Segment by Type

2.2.1 For Adults

2.2.2 For Children

2.3 Whole Cell Cholera Vaccine Sales by Type

2.3.1 Global Whole Cell Cholera Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Whole Cell Cholera Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Whole Cell Cholera Vaccine Sale Price by Type (2017-2022)

2.4 Whole Cell Cholera Vaccine Segment by Application

2.4.1 Clinical Research Institutes

2.4.2 Hospital

2.4.3 Surgical Centers

2.4.4 Others

2.5 Whole Cell Cholera Vaccine Sales by Application

2.5.1 Global Whole Cell Cholera Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Whole Cell Cholera Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Whole Cell Cholera Vaccine Sale Price by Application (2017-2022)

3 Global Whole Cell Cholera Vaccine by Company

3.1 Global Whole Cell Cholera Vaccine Breakdown Data by Company

3.1.1 Global Whole Cell Cholera Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Whole Cell Cholera Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Whole Cell Cholera Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Whole Cell Cholera Vaccine Revenue by Company (2020-2022)

3.2.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Whole Cell Cholera Vaccine Sale Price by Company

3.4 Key Manufacturers Whole Cell Cholera Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Whole Cell Cholera Vaccine Product Location Distribution

3.4.2 Players Whole Cell Cholera Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Whole Cell Cholera Vaccine by Geographic Region

4.1 World Historic Whole Cell Cholera Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Whole Cell Cholera Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Whole Cell Cholera Vaccine Annual Revenue by Geographic Region

4.2 World Historic Whole Cell Cholera Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Whole Cell Cholera Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Whole Cell Cholera Vaccine Annual Revenue by Country/Region

4.3 Americas Whole Cell Cholera Vaccine Sales Growth

4.4 APAC Whole Cell Cholera Vaccine Sales Growth

4.5 Europe Whole Cell Cholera Vaccine Sales Growth

4.6 Middle East & Africa Whole Cell Cholera Vaccine Sales Growth

5 Americas

5.1 Americas Whole Cell Cholera Vaccine Sales by Country

5.1.1 Americas Whole Cell Cholera Vaccine Sales by Country (2017-2022)

5.1.2 Americas Whole Cell Cholera Vaccine Revenue by Country (2017-2022)

5.2 Americas Whole Cell Cholera Vaccine Sales by Type

5.3 Americas Whole Cell Cholera Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Whole Cell Cholera Vaccine Sales by Region

6.1.1 APAC Whole Cell Cholera Vaccine Sales by Region (2017-2022)

6.1.2 APAC Whole Cell Cholera Vaccine Revenue by Region (2017-2022)

6.2 APAC Whole Cell Cholera Vaccine Sales by Type

6.3 APAC Whole Cell Cholera Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Whole Cell Cholera Vaccine by Country

7.1.1 Europe Whole Cell Cholera Vaccine Sales by Country (2017-2022)

7.1.2 Europe Whole Cell Cholera Vaccine Revenue by Country (2017-2022)

7.2 Europe Whole Cell Cholera Vaccine Sales by Type

7.3 Europe Whole Cell Cholera Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Whole Cell Cholera Vaccine by Country

8.1.1 Middle East & Africa Whole Cell Cholera Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Whole Cell Cholera Vaccine Sales by Type

8.3 Middle East & Africa Whole Cell Cholera Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Whole Cell Cholera Vaccine

10.3 Manufacturing Process Analysis of Whole Cell Cholera Vaccine

10.4 Industry Chain Structure of Whole Cell Cholera Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Whole Cell Cholera Vaccine Distributors

11.3 Whole Cell Cholera Vaccine Customer

12 World Forecast Review for Whole Cell Cholera Vaccine by Geographic Region

12.1 Global Whole Cell Cholera Vaccine Market Size Forecast by Region

12.1.1 Global Whole Cell Cholera Vaccine Forecast by Region (2023-2028)

12.1.2 Global Whole Cell Cholera Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Whole Cell Cholera Vaccine Forecast by Type

12.7 Global Whole Cell Cholera Vaccine Forecast by Application

13 Key Players Analysis

13.1 SBL Vaccine

13.1.1 SBL Vaccine Company Information

13.1.2 SBL Vaccine Whole Cell Cholera Vaccine Product Offered

13.1.3 SBL Vaccine Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 SBL Vaccine Main Business Overview

13.1.5 SBL Vaccine Latest Developments

13.2 PaxVax

13.2.1 PaxVax Company Information

13.2.2 PaxVax Whole Cell Cholera Vaccine Product Offered

13.2.3 PaxVax Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 PaxVax Main Business Overview

13.2.5 PaxVax Latest Developments

13.3 Valneva SE

13.3.1 Valneva SE Company Information

13.3.2 Valneva SE Whole Cell Cholera Vaccine Product Offered

13.3.3 Valneva SE Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Valneva SE Main Business Overview

13.3.5 Valneva SE Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Whole Cell Cholera Vaccine Product Offered

13.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 Johnson and Johnson

13.5.1 Johnson and Johnson Company Information

13.5.2 Johnson and Johnson Whole Cell Cholera Vaccine Product Offered

13.5.3 Johnson and Johnson Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Johnson and Johnson Main Business Overview

13.5.5 Johnson and Johnson Latest Developments

13.6 Merck

13.6.1 Merck Company Information

13.6.2 Merck Whole Cell Cholera Vaccine Product Offered

13.6.3 Merck Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck Main Business Overview

13.6.5 Merck Latest Developments

13.7 Pfizer

13.7.1 Pfizer Company Information

13.7.2 Pfizer Whole Cell Cholera Vaccine Product Offered

13.7.3 Pfizer Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Main Business Overview

13.7.5 Pfizer Latest Developments

13.8 Sanofi Pasteur

13.8.1 Sanofi Pasteur Company Information

13.8.2 Sanofi Pasteur Whole Cell Cholera Vaccine Product Offered

13.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Pasteur Main Business Overview

13.8.5 Sanofi Pasteur Latest Developments

13.9 AstraZeneca(Medimmune, LLC.)

13.9.1 AstraZeneca(Medimmune, LLC.) Company Information

13.9.2 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Offered

13.9.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 AstraZeneca(Medimmune, LLC.) Main Business Overview

13.9.5 AstraZeneca(Medimmune, LLC.) Latest Developments

13.10 Serum Institute of India

13.10.1 Serum Institute of India Company Information

13.10.2 Serum Institute of India Whole Cell Cholera Vaccine Product Offered

13.10.3 Serum Institute of India Whole Cell Cholera Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Serum Institute of India Main Business Overview

13.10.5 Serum Institute of India Latest Developments

14 Research Findings and Conclusion

Table 1. Whole Cell Cholera Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Whole Cell Cholera Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of For Adults

Table 4. Major Players of For Children

Table 5. Global Whole Cell Cholera Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Whole Cell Cholera Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Whole Cell Cholera Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Whole Cell Cholera Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Whole Cell Cholera Vaccine Revenue by Application (2017-2022)

Table 13. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Whole Cell Cholera Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Whole Cell Cholera Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Whole Cell Cholera Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Whole Cell Cholera Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Whole Cell Cholera Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Whole Cell Cholera Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Whole Cell Cholera Vaccine Producing Area Distribution and Sales Area

Table 21. Players Whole Cell Cholera Vaccine Products Offered

Table 22. Whole Cell Cholera Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Whole Cell Cholera Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Whole Cell Cholera Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Whole Cell Cholera Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Whole Cell Cholera Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Whole Cell Cholera Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Whole Cell Cholera Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Whole Cell Cholera Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Whole Cell Cholera Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Whole Cell Cholera Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Whole Cell Cholera Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Whole Cell Cholera Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Whole Cell Cholera Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Whole Cell Cholera Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Whole Cell Cholera Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Whole Cell Cholera Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Whole Cell Cholera Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Whole Cell Cholera Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Whole Cell Cholera Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Whole Cell Cholera Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Whole Cell Cholera Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Whole Cell Cholera Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Whole Cell Cholera Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Whole Cell Cholera Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Whole Cell Cholera Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Whole Cell Cholera Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Whole Cell Cholera Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Whole Cell Cholera Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Whole Cell Cholera Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Whole Cell Cholera Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Whole Cell Cholera Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Whole Cell Cholera Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Whole Cell Cholera Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Whole Cell Cholera Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Whole Cell Cholera Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Whole Cell Cholera Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Whole Cell Cholera Vaccine

Table 66. Key Market Challenges & Risks of Whole Cell Cholera Vaccine

Table 67. Key Industry Trends of Whole Cell Cholera Vaccine

Table 68. Whole Cell Cholera Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Whole Cell Cholera Vaccine Distributors List

Table 71. Whole Cell Cholera Vaccine Customer List

Table 72. Global Whole Cell Cholera Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Whole Cell Cholera Vaccine Sales Market Forecast by Region

Table 74. Global Whole Cell Cholera Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Whole Cell Cholera Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Whole Cell Cholera Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Whole Cell Cholera Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Whole Cell Cholera Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Whole Cell Cholera Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Whole Cell Cholera Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Whole Cell Cholera Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Whole Cell Cholera Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Whole Cell Cholera Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Whole Cell Cholera Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Whole Cell Cholera Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Whole Cell Cholera Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Whole Cell Cholera Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Whole Cell Cholera Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Whole Cell Cholera Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Whole Cell Cholera Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Whole Cell Cholera Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. SBL Vaccine Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. SBL Vaccine Whole Cell Cholera Vaccine Product Offered

Table 94. SBL Vaccine Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. SBL Vaccine Main Business

Table 96. SBL Vaccine Latest Developments

Table 97. PaxVax Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. PaxVax Whole Cell Cholera Vaccine Product Offered

Table 99. PaxVax Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. PaxVax Main Business

Table 101. PaxVax Latest Developments

Table 102. Valneva SE Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Valneva SE Whole Cell Cholera Vaccine Product Offered

Table 104. Valneva SE Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Valneva SE Main Business

Table 106. Valneva SE Latest Developments

Table 107. GlaxoSmithKline Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. GlaxoSmithKline Whole Cell Cholera Vaccine Product Offered

Table 109. GlaxoSmithKline Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. GlaxoSmithKline Main Business

Table 111. GlaxoSmithKline Latest Developments

Table 112. Johnson and Johnson Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Johnson and Johnson Whole Cell Cholera Vaccine Product Offered

Table 114. Johnson and Johnson Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Johnson and Johnson Main Business

Table 116. Johnson and Johnson Latest Developments

Table 117. Merck Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Merck Whole Cell Cholera Vaccine Product Offered

Table 119. Merck Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Merck Main Business

Table 121. Merck Latest Developments

Table 122. Pfizer Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Pfizer Whole Cell Cholera Vaccine Product Offered

Table 124. Pfizer Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Pfizer Main Business

Table 126. Pfizer Latest Developments

Table 127. Sanofi Pasteur Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Sanofi Pasteur Whole Cell Cholera Vaccine Product Offered

Table 129. Sanofi Pasteur Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Sanofi Pasteur Main Business

Table 131. Sanofi Pasteur Latest Developments

Table 132. AstraZeneca(Medimmune, LLC.) Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Offered

Table 134. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. AstraZeneca(Medimmune, LLC.) Main Business

Table 136. AstraZeneca(Medimmune, LLC.) Latest Developments

Table 137. Serum Institute of India Basic Information, Whole Cell Cholera Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Serum Institute of India Whole Cell Cholera Vaccine Product Offered

Table 139. Serum Institute of India Whole Cell Cholera Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Serum Institute of India Main Business

Table 141. Serum Institute of India Latest Developments

List of Figures

Figure 1. Picture of Whole Cell Cholera Vaccine

Figure 2. Whole Cell Cholera Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Whole Cell Cholera Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Whole Cell Cholera Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Whole Cell Cholera Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of For Adults

Figure 10. Product Picture of For Children

Figure 11. Global Whole Cell Cholera Vaccine Sales Market Share by Type in 2021

Figure 12. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Whole Cell Cholera Vaccine Consumed in Clinical Research Institutes

Figure 14. Global Whole Cell Cholera Vaccine Market: Clinical Research Institutes (2017-2022) & (K Units)

Figure 15. Whole Cell Cholera Vaccine Consumed in Hospital

Figure 16. Global Whole Cell Cholera Vaccine Market: Hospital (2017-2022) & (K Units)

Figure 17. Whole Cell Cholera Vaccine Consumed in Surgical Centers

Figure 18. Global Whole Cell Cholera Vaccine Market: Surgical Centers (2017-2022) & (K Units)

Figure 19. Whole Cell Cholera Vaccine Consumed in Others

Figure 20. Global Whole Cell Cholera Vaccine Market: Others (2017-2022) & (K Units)

Figure 21. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2017-2022)

Figure 22. Global Whole Cell Cholera Vaccine Revenue Market Share by Application in 2021

Figure 23. Whole Cell Cholera Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Whole Cell Cholera Vaccine Revenue Market Share by Company in 2021

Figure 25. Global Whole Cell Cholera Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Whole Cell Cholera Vaccine Revenue Market Share by Geographic Region in 2021

Figure 27. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2017-2022)

Figure 28. Global Whole Cell Cholera Vaccine Revenue Market Share by Country/Region in 2021

Figure 29. Americas Whole Cell Cholera Vaccine Sales 2017-2022 (K Units)

Figure 30. Americas Whole Cell Cholera Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. APAC Whole Cell Cholera Vaccine Sales 2017-2022 (K Units)

Figure 32. APAC Whole Cell Cholera Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Europe Whole Cell Cholera Vaccine Sales 2017-2022 (K Units)

Figure 34. Europe Whole Cell Cholera Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Whole Cell Cholera Vaccine Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Whole Cell Cholera Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Americas Whole Cell Cholera Vaccine Sales Market Share by Country in 2021

Figure 38. Americas Whole Cell Cholera Vaccine Revenue Market Share by Country in 2021

Figure 39. United States Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Whole Cell Cholera Vaccine Sales Market Share by Region in 2021

Figure 44. APAC Whole Cell Cholera Vaccine Revenue Market Share by Regions in 2021

Figure 45. China Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Whole Cell Cholera Vaccine Sales Market Share by Country in 2021

Figure 52. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country in 2021

Figure 53. Germany Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Whole Cell Cholera Vaccine Revenue Market Share by Country in 2021

Figure 60. Egypt Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Whole Cell Cholera Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Whole Cell Cholera Vaccine in 2021

Figure 66. Manufacturing Process Analysis of Whole Cell Cholera Vaccine

Figure 67. Industry Chain Structure of Whole Cell Cholera Vaccine

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles